VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization
Incidence of Venous Thromboembolism After Lower Limb Revascularization in Patients Receiving Rivaroxaban 2.5 Mg Bid + Aspirin 100 Mg Versus Single Antiplatelet Treatment - a Randomized Clinical Trial
Vascular Surgery Patient with PAD / Carotid Stenosis